The CC genotype of rs2010963 is associated with higher serum levels of VEGF protein in patients with proliferative diabetic retinopathy (44), and breast cancer patients with a higher plasma VEGF concentration are the worst responders to bevacizumab (45). Here, VEGFA is linked to breast carcinoma.